A. Wood

发表

C. K. Cain, A. Doherty, A. Wood, 2002 .

Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity

David A. Price, A. Wood, P. Dorr, 2005, Antimicrobial Agents and Chemotherapy.

The design and discovery of novel amide CCR5 antagonists.

David W. Gordon, D. Gordon, A. Wood, 2009, Bioorganic & medicinal chemistry letters.

Reduction of 4-oxo α-amino acids as a route to 4-hydroxylated α-amino acids. Concise approaches to the synthesis of clavalanine, erythro-4-hydroxyornithine and (+)-bulgecinine

A. Wood, M. Wythes, R. Jackson, 1994 .

Behavioural and neurophysiological responses of Spodoptera littoralis to azadirachtin and a range of synthetic analogues

A. Wood, S. Ley, R. B. Grossman, 1995 .

The chemistry of azadirachtin

A. Wood, S. Ley, A. Denholm, 1993 .

The Discovery of Tropane‐derived CCR5 Receptor Antagonists

David A. Price, A. Wood, M. D. de Groot, 2006, Chemical biology & drug design.

Inhalation by design: novel tertiary amine muscarinic M₃ receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease.

M. Bunnage, David A. Price, A. Wood, 2011, Journal of medicinal chemistry.

Overcoming hERG affinity in the discovery of maraviroc; a CCR5 antagonist for the treatment of HIV.

David A. Price, A. Wood, M. D. de Groot, 2008, Current topics in medicinal chemistry.

Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity

David A. Price, A. Wood, P. Dorr, 2005, Antimicrobial Agents and Chemotherapy.

Organic synthesis provides opportunities to transform drug discovery

Anthony Wood, Andrew W. Thomas, David M. Wilson, 2018, Nature Chemistry.

Ketone-directed peracid epoxidation of cyclic alkenes

A. Armstrong, A. Wood, P. Clarke, 1996 .

Ketone-directed peracid epoxidation

A. Armstrong, A. Wood, P. Clarke, 1994 .

The synthesis of azadirachtin: a potent insect antifeedant.

D. Jennens, M. Göbel, A. Wood, 2008, Chemistry.

The chemistry of azadirachtin

A. Wood, S. Ley, A. Denholm, 1993 .

Evidence that a dioxirane is not responsible for alkene epoxidation in a ketone–Oxone® system

A. Armstrong, A. Wood, P. Clarke, 1996 .

Ketone-Directed Peracid Epoxidation.

A. Armstrong, A. Wood, P. Clarke, 1995 .

Pyrazole NNRTIs 4: selection of UK-453,061 (lersivirine) as a development candidate.

David A. Price, A. Wood, R. Corbau, 2009, Bioorganic & medicinal chemistry letters.

Preparation of enantiomerically pure protected 4-oxo .alpha.-amino acids and 3-aryl .alpha.-amino acids from serine

K. James, A. Wood, M. Wythes, 1992 .

Synthesis of enantiomerically pure protected β-aryl alanines

A. Wood, M. Wythes, R. Jackson, 1989 .

A new direct method for the synthesis of enantiomerically pure protected α-amino acids

K. James, A. Wood, M. Wythes, 1989 .

Sexual development of malaria parasites is inhibited in vitro by the neem extract azadirachtin, and its semi-synthetic analogues.

R. Sinden, A. Wood, S. Ley, 1994, FEMS microbiology letters.

Effect of azadirachtin-derived decalin (perhydronaphthalene) and dihydrofuranacetal (furo[2, 3-fo]pyran) fragments on the feeding behaviour of Spodoptera littoralis

A. Wood, S. Ley, M. Simmonds, 1994 .

Chemistry of insect antifeedants from Azadirachta indica (part 11): Characterisation and structure activity relationships of some novel rearranged azadirachtins. ☆

David J. Williams, E. Morgan, A. Slawin, 1991 .

The Discovery of CCR5 Receptor Antagonists for the Treatment of HIV Infection: Hit‐to‐Lead Studies

David A. Price, A. Wood, M. Edwards, 2006, ChemMedChem.

The discovery of the CCR5 receptor antagonist, UK-427,857, a new agent for the treatment of HIV infection and AIDS.

Anthony Wood, A. Wood, Duncan Armour, 2005, Progress in medicinal chemistry.

Lersivirine, a Nonnucleoside Reverse Transcriptase Inhibitor with Activity against Drug-Resistant Human Immunodeficiency Virus Type 1

A. Wood, Chris Phillips, T. Knöchel, 2010, Antimicrobial Agents and Chemotherapy.

An Approach to the Synthesis of Enantiomerically Pure Hydroxylated α-Amino Acids Using Zinc Homoenolate Chemistry

A. Wood, M. Wythes, R. Jackson, 1990 .

An Approach to the Synthesis of Enantiomerically Pure Hydroxylated α-Amino Acids using Zinc Homoenolate Chemistry.

A. Wood, M. Wythes, R. Jackson, 1991 .

Depressed activities of purine enzymes in lymphocytes of patients infected with human immunodeficiency virus.

I. Frazer, A. Wood, A. Chalmers, 1989, Clinical chemistry.

Pyrazole NNRTIs 1: design and initial optimisation of a novel template.

A. Wood, R. Corbau, C. Mowbray, 2009, Bioorganic & medicinal chemistry letters.

Preparation of Enantiomerically Pure Protected 4-Oxo-α-amino Acids and 3-Aryl-α-amino Acids from Serine.

K. James, A. Wood, M. Wythes, 1992 .

Chemistry of insect antifeedants from Azadirachta Indica (Part 15):1 Degradation studies of Azadirachtin leading to C8C14 bond cleavage.

A. Slawin, A. Wood, S. Ley, 1993 .

Chemistry of Insect Antifeedants from Azadirachta indica. Part 15. Degradation Studies of Azadirachtin Leading to C8‐C14 Bond Cleavage

A. Slawin, A. Wood, S. Ley, 1993 .

An imidazopiperidine series of CCR5 antagonists for the treatment of HIV: the discovery of N-{(1S)-1-(3-fluorophenyl)-3-[(3-endo)-3-(5-isobutyryl-2-methyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]propyl}acetamide (PF-232798).

A. Wood, P. Dorr, D. Pryde, 2011, Journal of medicinal chemistry.

Metabolism-directed design of oxetane-containing arylsulfonamide derivatives as γ-secretase inhibitors.

L. Pustilnik, A. Stepan, R. Obach, 2011, Journal of medicinal chemistry.

Overcoming HERG affinity in the discovery of the CCR5 antagonist maraviroc.

David A. Price, A. Wood, M. D. de Groot, 2006, Bioorganic & medicinal chemistry letters.

Highly potent and selective chiral inhibitors of PDE5: an illustration of Pfeiffer's rule.

M. Bunnage, J. Mathias, A. Wood, 2008, Bioorganic & medicinal chemistry letters.

Pyrazole NNRTIs 3: optimisation of physicochemical properties.

A. Wood, R. Corbau, C. Mowbray, 2009, Bioorganic & medicinal chemistry letters.